Prostate Cancer - Results from #25160

Current evidence about intermittent androgenic deprivation in prostate cancer - Abstract August 8, 2012

Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer - Abstract August 8, 2012

Risk factors and predictors of prostate cancer in men with negative repeat saturation biopsy - Abstract August 8, 2012

Partners' long-term appraisal of their caregiving experience, marital satisfaction, sexual satisfaction, and quality of life 2 years after prostate cancer treatment - Abstract August 8, 2012

DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time - Abstract August 8, 2012

Biopsy findings of low-risk prostate disease: Are they real? Single centre experience - Abstract August 8, 2012

Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75 years old - Abstract August 8, 2012

Implications of CT imaging for postplan quality assessment in prostate brachytherapy - Abstract August 8, 2012

Undetectable prostate-specific antigen level following prostate brachytherapy: An apples-to-apples comparison with radical prostatectomy - Abstract August 8, 2012

Is the transitional zone biopsy specimen significant for prostate cancer detection? - Abstract August 8, 2012

The value of digital rectal examination in men with lower urinary tract symptoms and prostate-specific antigen less than 3 ng/ml - Abstract August 8, 2012

Lymphadenectomy and prostate cancer: A statement of the committee of cancerology of the French association of urology - Abstract August 8, 2012

Surgical strategies to promote early continence recovery after robotic radical prostatectomy - Abstract August 8, 2012

AST-induced bone loss in men with prostate cancer: Exercise as a potential countermeasure - Abstract August 8, 2012

Change of the LHRH analogue in progressive castration-refractory prostate cancer - Abstract August 8, 2012

The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: A systematic review and meta-analysis - Abstract August 8, 2012

Prostate cancer screening practices in the Republic of Ireland: The determinants of uptake - Abstract August 8, 2012

Long-term potency preservation following brachytherapy for prostate cancer - Abstract August 8, 2012

Open, multi-center, phase IV study to assess the efficacy and tolerability of triptorelin in Taiwanese patients with advanced prostate cancer - Abstract August 7, 2012

SEOM clinical guidelines for treatment of prostate cancer - Abstract August 7, 2012

Page 1259 of 1435